PMID- 19606713
OWN - NLM
STAT- MEDLINE
DCOM- 20091006
LR  - 20151119
IS  - 1426-9686 (Print)
IS  - 1426-9686 (Linking)
VI  - 26
IP  - 155
DP  - 2009 May
TI  - [Gastroesophageal reflux disease--diagnosis and management].
PG  - 512-6
AB  - Gastroesophageal reflux disease is a serious clinical problem. In clinical 
      classification of gastroesophageal reflux disease we differentiate esophageal and 
      non-esophageal syndromes. In case of esophageal syndromes we differentiate based 
      on clinical signs and syndromes with esophageal mucosal lesions based diagnosed 
      on base of upper alimentary tract endoscopic and histopathologic assessment. In 
      clinical diagnosis establishing basics are clinical symptoms as heartburn, 
      regurgitation. Usually, recently found typical symptoms of light intensification 
      can be concluded with diagnosis gastroesophageal reflux disease and without other 
      diagnostic tools treatment could be introduced. Helpful diagnostic test is a test 
      with proton pump inhibitors. Endoscopic assessment should be performed at least 
      once in every patient with chronic gastroesophageal reflux disease in order to 
      eliminate complications (Barrett disease). Main impedance advantage is 
      possibility of reflux diagnosis disregarding ph value. Continuous monitoring of 
      impedance in many segments of esophagus can help to establish direction of reflux 
      and its characteristics and extent establishment. (liquid, gaseous, mixed). The 
      main role in pharmacological gastroesophageal reflux disease treatment plays 
      drugs decreasing acid output, proton pump inhibitors (PPI). Dosage of chronic use 
      should be assess individually. The Basic rule is the use of possibly minimal 
      therapeutic dose of PPI. In this paper authors presented basics of 
      gastroesophageal reflux disease diagnosing, monitoring and treatment.
FAU - Wojtun, Stanislaw
AU  - Wojtun S
AD  - Military Institute of Health Services in Warsaw, Department of Gastroenterology, 
      Central Clinical Hospital of the Ministry of National Defense.
FAU - Gil, Jerzy
AU  - Gil J
FAU - Jalocha, Lukasz
AU  - Jalocha L
FAU - Blaszak, Antoni
AU  - Blaszak A
FAU - Wojtkowiak, Marek
AU  - Wojtkowiak M
LA  - pol
PT  - English Abstract
PT  - Journal Article
PT  - Review
TT  - Choroba refluksowa przelyku--rozpoznawanie i leczenie.
PL  - Poland
TA  - Pol Merkur Lekarski
JT  - Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
JID - 9705469
RN  - 0 (Proton Pump Inhibitors)
SB  - IM
MH  - Barrett Esophagus/etiology/prevention & control
MH  - Chronic Disease
MH  - Esophageal Diseases/diagnosis/etiology/pathology
MH  - Esophagoscopy
MH  - Gastroesophageal Reflux/complications/*diagnosis/*drug therapy
MH  - Humans
MH  - Proton Pump Inhibitors/therapeutic use
RF  - 17
EDAT- 2009/07/18 09:00
MHDA- 2009/10/07 06:00
CRDT- 2009/07/18 09:00
PHST- 2009/07/18 09:00 [entrez]
PHST- 2009/07/18 09:00 [pubmed]
PHST- 2009/10/07 06:00 [medline]
PST - ppublish
SO  - Pol Merkur Lekarski. 2009 May;26(155):512-6.